Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Q32 Bio (QTTB) Net Margin (2018 - 2023)

Historic Net Margin for Q32 Bio (QTTB) over the last 6 years, with Q4 2023 value amounting to 1957.52%.

  • Q32 Bio's Net Margin rose 23529500.0% to 1957.52% in Q4 2023 from the same period last year, while for Sep 2024 it was 1670.72%, marking a year-over-year increase of 23656700.0%. This contributed to the annual value of 0.81% for FY2023, which is 158600.0% down from last year.
  • Per Q32 Bio's latest filing, its Net Margin stood at 1957.52% for Q4 2023, which was up 23529500.0% from 754.76% recorded in Q3 2023.
  • Q32 Bio's Net Margin's 5-year high stood at 11553.99% during Q1 2022, with a 5-year trough of 8834.07% in Q1 2019.
  • Over the past 5 years, Q32 Bio's median Net Margin value was 3714.28% (recorded in 2022), while the average stood at 2876.41%.
  • As far as peak fluctuations go, Q32 Bio's Net Margin skyrocketed by 115576500bps in 2022, and later plummeted by -117860200bps in 2023.
  • Over the past 5 years, Q32 Bio's Net Margin (Quarter) stood at 4292.54% in 2019, then grew by 29bps to 3039.9% in 2020, then tumbled by -38bps to 4187.41% in 2021, then decreased by -3bps to 4310.47% in 2022, then surged by 55bps to 1957.52% in 2023.
  • Its last three reported values are 1957.52% in Q4 2023, 754.76% for Q3 2023, and 181.19% during Q2 2023.